CVDs are the number 1 cause of death globally: more people die annually from CVDs than from any other cause.
An estimated 17.5 million people died from CVDs in 2012, representing 31% of all global deaths. Of these deaths, an estimated 7.4 million were due to coronary heart disease and 6.7 million were due to stroke .
Over three quarters of CVD deaths take place in low- and middle-income countries.
Out of the 16 million deaths under the age of 70 due to noncommunicable diseases, 82% are in low and middle income countries and 37% are caused by CVDs.
Most cardiovascular diseases can be prevented by addressing behavioural risk factors such as tobacco use, unhealthy diet and obesity, physical inactivity and harmful use of alcohol using population-wide strategies.
People with cardiovascular disease or who are at high cardiovascular risk (due to the presence of one or more risk factors such as hypertension, diabetes, hyperlipidaemia or already established disease) need early detection and management using counselling and medicines, as appropriate.
Involving patients is critical to reducing the economic, social and emotional burden of heart diseases and improves the lives of patients with the condition everywhere.
Patients are often diagnosed late, underdiagnosed, and are frequently undertreated or inadequately treated for the condition. This needs to change. People with heart diseases deserve a higher quality of care and access to recognised gold standard treatments.
We are committed to building a global network of patient organisations that will provide support and improve patient outcomes.
Local patient organisations play a vital role in driving tangible change. From a global level, we can define and clarify the severity of the problem but we cannot do this alone. We need to gather local insights and collaborate with the patient, medical and political communities around the world.